Clinical Research Directory

Inclusion Criteria: * All English-speaking adult MD Anderson patients with hematologic malignancy at 6-12 months +/- 8 weeks post allogeneic stem cell transplantation who will receive usual post-stem cell transplant vaccinations * All patients from approved protocol 2015-0795 will be invited to this vaccine study Exclusion Criteria: * Prior allogeneic SCT * Platelet count less than or equal to 25,000 K/uL * Absolute neutrophil count less than or equal to 500/uL * Patients who have ever received HPV vaccination (at least one dose of HPV vaccine) * Patients with a prior history of HPV-related malignancy * Female patients who tested positive for pregnancy during pre-SCT evaluation